Intellia Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of NTLA for the last quarter is 6.96 M USD, and it's 75.96% lower compared to the previous quarter. The net income of Q2 24 is -146.97 M USD.